Plasvacc
24/7 HELP HOTLINE WITHIN AUSTRALIA 1800 752 762
  • Home
  • Products
    • Products overview
    • Equiplas
    • Equiplas-R
    • Equiplas-E
    • Caniplas
    • Caniplas E
    • CaniPRBC
    • Camelplas
    • Diagnostic Kits
  • How to buy
  • Technology
    • Plasma Therapy
    • Collection process
    • Thawing instructions
    • Product usage
    • Storage
  • Research
    • Scientific papers
    • White papers
    • Background papers
  • About
    • Company overview
    • Animal ethics
    • Plasvacc team
    • Regional commitment
  • Blog
  • Contact

Caniplas and Parvovirus

Home» Product Science » Caniplas and Parvovirus

Caniplas and Parvovirus

Since its discovery in the late 1970s, canine parvovirus has been one of the leading causes of death in dogs due to its highly resilient, contagious, and aggressive nature. The fatality rate for puppies and unvaccinated dogs can be as high as 90% if left untreated. Parvovirus is easily transmitted through direct and indirect contact, is resistant to antivirals and disinfectants, and is very fast-moving once a host is infected. Because there is currently no cure for parvovirus, supportive care is essential while the dog fights the infection.

Veterinarians who see patients with parvovirus know that immediate treatment is essential. The virus is extremely contagious and can do significant amounts of damage in a short period of time. Caniplas, Plasvacc’s hyperimmunised plasma, helps support the body’s organ systems by promoting clotting, controlling inflammation, and giving the dog the lifesaving antibodies it needs to heal and recover.

“Life in a Bag”

Veterinarians tell us having Caniplas in their freezer gives them great peace of mind. It’s reassuring to know that they have a safe, natural treatment readily available when a dog comes in with parvovirus. After experiencing the results firsthand, client and veterinarian Brett Stone says when he tells people about Caniplas, “We’ve seen it bring dogs back to life; I call it life in a bag, [because] it just has so many life-giving properties…”.

Puppies are especially vulnerable to parvovirus until they have completed their vaccination series—usually around 12 weeks of age. If they do get infected, the prognosis is dire without immediate treatment. In a study of dogs with parvovirus enteritis, it was found that in neonatal care, Caniplas “greatly improved the cardiovascular parameters of the puppies…in the first 24 hours post-transfusion.” Download the study here: Download

Caniplas is an investment in the health and longevity of your animals. While parvovirus can be one of the most expensive infections to treat, Caniplas has been shown to pay for itself by reducing the length of hospital stays, as well as the need for extended acute care and prescribed medications. With the use of Caniplas, the patient’s long-term prognosis is markedly improved.

At Plasvacc, all of our APVMA & NZFSA – registered plasma products are manufactured to strict protocols and undergo stringent purity and safety testing. Caniplas has been relied upon by veterinarians and breeders around the world for years. With low risk and high efficacy, Caniplas is the obvious choice for veterinarians.

To learn more about Caniplas, or any of our other biological products, reach out to us here, or give our office a call at 61 7 5463 7600. We are always happy to answer any questions you may have.

Comments are closed.

FoalsBestStart.com
Want the best for your dog?
See more products

About us

Plasvacc manufactures and distributes high quality hyperimmunised blood plasma products used to supplement the immune response system in animals. Plasma therapy shortens the course of treatments, reduces hospitalisation periods and lessens the quantity of drugs required to treat a variety of medical conditions.

SIGN UP FOR OUR MAILING LIST





    Contact us

    • Telephone: +61 7 5463 7600
    • Technical Support: 1-800-PLASMA | 1-800-752762
    • plasmail@plasvacc.com
    • Contact Us
      • ✉
      • 
      • 
      • 
    • Products
      • Equiplas
      • Equiplas-R
      • Equiplas-E
      • Caniplas
      • Caniplas E
      • CaniPRBC
      • Camelplas
      • Diagnostic Kits
    • How to buy
      • Wholesalers
    • Company overview
      • Plasvacc team
      • Animal ethics
      • Regional commitment
    • Research
      • Scientific papers
      • Background papers
      • White papers
    • Technology
      • Plasma therapy
      • Collection process
      • Thawing Instructions
      • Product usage
      • Storage

    (c) 2012 Plasvacc | All Rights Reserved | privacy policy

    Manage Cookie Consent
    We use cookies to optimise our website and our service.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    Preferences
    {title} {title} {title}